期刊文献+

重视白塞病多系统损害的诊治

原文传递
导出
摘要 白塞病(Behcet’s disease,BD)除口腔溃疡、生殖器溃疡和前葡萄膜炎这三种具有特征性的表现外,血管、胃肠道、肺、肾和中枢系统等多脏器均可受累,是一种典型的累及多系统的慢性疾病。
作者 李向培
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2009年第8期513-515,共3页 Chinese Journal of Rheumatology
  • 相关文献

参考文献15

  • 1董怡.贝赫切特病[A].蒋明 DavidYu 林孝义.中华风湿病学[C].北京:华夏出版社,2004.1194-1203.
  • 2Idil A, Gurler A, Boyvat A, et al. The prevalence of Behcet's disease above the age of 10 years: the results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Ophthalmic Epidemiol, 2002, 9: 325-331.
  • 3Azizlerli G, Kose AA, Sarica R, et al. Prevalence of Behcet's disease in Istanbul, Turkey. Int J Dermatol, 2003, 42: 803-806.
  • 4Yi D, Shi GY. The synopsis of the 8th international meeting on BD. Nat Med J China, 1999, 38: 135-136.
  • 5Dalghous AM, Freysdottir J, Fortune F, et al. Expression of cytokines, chemokines and chemokine receptors in oral ulcers of patients with Behqet's disease (BD) and recurrent aphthous stomatitis is Thl associated, although Th2 association is also observed in patients with BD. Scand J Rheumatol, 2006, 35: 472-475.
  • 6Espinosa G, Font J, Tassies D, et al. Vascular involvement in Behcet's disease: relation with thrombophilic factors, coagulation activation and thrombomodulin. Am J Med, 2002, 112: 37-43.
  • 7Krause I ,Weinberger A. Behqet's disease. Curr Opin Rheumatol, 2008, 20: 82-87.
  • 8Lie JT. Vascular involvement in Behcet's disease: arterial and venous and vessels of all sizes. J Rheumatol, 1992, 19: 341-343.
  • 9Siva A, Kantarci OH, Saip S, et al. Behcet's disease: diagnostic and prognostic aspects of neurological involvement. J Neurol, 2001, 248: 95-103.
  • 10Bayraktar Y, Ozaslan E, Van Thiel DH. Gastrointestinal manifestations of Behcet's disease. J Clin Gastroenterol, 2000, 30: 144-154.

二级参考文献30

  • 1张士发,王良明,张海涛,顾苏宁.白塞氏病125例临床分析[J].皮肤病与性病,1996,18(4):8-9. 被引量:3
  • 2International study group for Behcet' s disease. Criteria for diagnosis of Behcet' s disease. Lancet, 1990,335 : 1078-1080.
  • 3Mok CC, Cheng TC, Ho CT, et al. Behcet' s disease in southern chinese patients. J Rheumatol,2002,29:1689-1693.
  • 4Kural-Seyahi E, Fresko I, Seyahi N, et al. The long-term mortality and morbility of Behcet' s syndrome. A 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine,2003,82:60-67.
  • 5Zouboulis CC, Vaiopoulos G, Marcomichelakis N. Onset signs,clinical course, prognosis, treatment and outcome of adult patients with Adamantiades-Behcet' s disease in Greece. Clin Exp Rheumatol,2003,21Suppl30 : S19-26.
  • 6Krause I, Monselise Y, Milo G, et al, Anti-Saccharomyces cerevisiae antibodies-A novel serologic marker for Behcet' s disease, Clin Exp Rheumatol,2002,20Suppl 26 : S21-24,
  • 7A1-Araji A, Sharquie K, A1-Rawi Z, Prevalence and patterns of neurological involvement in Behcet' s disease : a prospective study from Iraq, J Neurol Neurosurg Psychiatry,2003,74:608-613,
  • 8Siva A, Ahintas A, Saip S, Beheet' s syndrome and the nervous system, Curr Opin Neurol,2004 ,17 :347-357.
  • 9Siva A,Kantarci OH,Saip S,et al. Behcet' s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol, 2001,248 :95-103,
  • 10Zouboulis CC, Tumbull JR, Martus P. Univariate and multivariate analyses comparing demographic, genetic, clinical, and serological risk factors for severe Adamantiades-Behcet' s disease. Adv Exp Med Biol,2003,528 : 123-126.

共引文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部